PLCB3 and acute lymphoblastic leukemia: Our data showing that the 14–22 amide (myr) PKA inhibitor alone reduced the levels of pSer118-BAD and pSer1105-PLCβ3, which are part of the above two apoptotic pathways, respectively (Figure 7B), led us to examine whether 14–22 amide (myr) induces ALL cell apoptosis.